Factors Associated with Overt Stroke in Children and Adolescents with Sickle Cell Disease: A Retrospective Cohort Study

References

• Pinto VM, Balocco M, Quintino S, et al. Sickle cell disease: a review for the internist. Intern Emerg Med. 2019;14(7):1051–1064. doi: 10.1007/s11739-019-02160-x.
   PubMed Web of Science ®Google Scholar
• Rankine-Mullings AE, Logan TM, King LG, et al. The risk of acute events among patients with sickle cell disease in relation to early or late initiation of care at a specialist center: evidence from a retrospective cohort study. BMC Pediatr. 2020;20(1):373–381. doi: 10.1186/s12887-020-02270-y.
   PubMed Web of Science ®Google Scholar
• Dutra VF, Biassi TP, Figueiredo MS. Sickle cell anemia: hierarchical cluster analysis and clinical profile in a cohort in Brazil. Hematol Transfus Cell Ther. 2023;45:45–51. doi: 10.1016/j.htct.2021.08.015.
   PubMedGoogle Scholar
• Platt OS, Thorington BD, Brambilla DJ, et al. Pain in sickle cell disease. Rates and risk factors. N Engl J Med. 1991;325(1):11–16. doi: 10.1056/NEJM199107043250103.
   PubMed Web of Science ®Google Scholar
• Ballas SK, Lieff S, Benjamin LJ, et al. Definitions of the phenotypic manifestations of sickle cell disease. Am J Hematol. 2010;85(1):6–13. doi: 10.1002/ajh.21550.
   PubMed Web of Science ®Google Scholar
• Jain D, Tokalwar R, Upadhye D, et al. Homozygous sickle cell disease in Central India & Jamaica: a comparison of newborn cohorts. Indian J Med Res. 2020;151(4):326–332. doi: 10.4103/ijmr.IJMR_1946_18.
   PubMed Web of Science ®Google Scholar
• Verduzco LA, Nathan DG. Sickle cell disease and stroke. Blood. 2009;114(25):5117–5125. doi: 10.1182/blood-2009-05-220921.
   PubMed Web of Science ®Google Scholar
• Lee MT, Piomelli S, Granger S, et al. Stroke Prevention Trial in Sickle Cell Anemia (STOP): extended follow-up and final results. Blood. 2006;108(3):847–852. doi: 10.1182/blood-2005-10-009506.
   PubMed Web of Science ®Google Scholar
• Houwing ME, Grohssteiner RL, Dremmen MH, et al. Silent cerebral infarcts in patients with sickle cell disease: a systematic review and meta-analysis. BMC Med. 2020;18(1):393. doi: 10.1186/s12916-020-01864-8.
   PubMed Web of Science ®Google Scholar
• Rees DC, Brousse VA, Brewin JN. Determinants of severity in sickle cell disease. Blood Rev. 2022;56:100983. doi: 10.1016/j.blre.2022.100983.
   PubMed Web of Science ®Google Scholar
• Kato GJ, Piel FB, Reid CD, et al. Sickle cell disease. Nat Rev Dis Primers. 2018;4(1):18010. doi: 10.1038/nrdp.2018.10.
   PubMedGoogle Scholar
• Belisário AR, Silva CM, Velloso-Rodrigues C, et al. Genetic, laboratory and clinical risk factors in the development of overt ischemic stroke in children with sickle cell disease. Hematol Transfus Cell Ther. 2018;40(2):166–181. doi: 10.1016/j.bjhh.2017.08.008.
   PubMedGoogle Scholar
• Piel FB, Steinberg MH, Rees DC. Sickle cell disease. N Engl J Med. 2017;376(16):1561–1573. doi: 10.1056/NEJMra1510865.
   PubMed Web of Science ®Google Scholar
• Domingos IF, Falcão DA, Hatzlhofer BL, et al. Influence of the βs haplotype and α-thalassemia on stroke development in a Brazilian population with sickle cell anaemia. Ann Hematol. 2014;93(7):1123–1129. doi: 10.1007/s00277-014-2016-1.
   PubMed Web of Science ®Google Scholar
• Raphael JL, Oyeku SO, Kowalkowski MA, et al. Trends in blood transfusion among hospitalized children with sickle cell disease. Pediatr Blood Cancer. 2013;60(11):1753–1758. doi: 10.1002/pbc.24630.
   PubMed Web of Science ®Google Scholar
• Kirkham FJ, Lagunju IA. Epidemiology of stroke in sickle cell disease. J Clin Med. 2021;10(18):4232. doi: 10.3390/jcm10184232.
   PubMed Web of Science ®Google Scholar
• Ohene-Frempong K, Weiner SJ, Sleeper LA, et al. Cerebrovascular accidents in sickle cell disease: rates and risk factors. Blood. 1998;91(1):288–294.
   PubMed Web of Science ®Google Scholar
• Tozatto-Maio K, Girot R, Ly ID, et al. Polymorphisms in inflammatory genes modulate clinical complications in patients with sickle cell disease. Front Immunol. 2020;11:2041. doi: 10.3389/fimmu.2020.02041.
   PubMed Web of Science ®Google Scholar
• DeBaun MR, Armstrong FD, McKinstry RC, et al. Silent cerebral infarcts: a review on a prevalent and progressive cause of neurologic injury in sickle cell anemia. Blood. 2012;119(20):4587–4596. doi: 10.1182/blood-2011-02-272682.
   PubMed Web of Science ®Google Scholar
• Adams RJ. Big strokes in small persons. Arch Neurol. 2007;64(11):1567–1574. doi: 10.1001/archneur.64.11.1567.
   PubMedGoogle Scholar
• Pegelow CH, Macklin EA, Moser FG, et al. Longitudinal changes in brain magnetic resonance imaging findings in children with sickle cell disease. Blood. 2002;99(8):3014–3018. doi: 10.1182/blood.v99.8.3014.
   PubMed Web of Science ®Google Scholar
• Angulo IL. Stroke and other vascular complications of the central nervous system in sickle cell disease. Rev Bras Hematol Hemoter. 2007;29(3):262–267.
   Google Scholar
• Majumdar S, Miller M, Khan M, et al. Outcome of overt stroke in sickle cell anaemia, a single institution’s experience. Br J Haematol. 2014;165(5):707–713. doi: 10.1111/bjh.12795.
   PubMed Web of Science ®Google Scholar
• Kilinç Y. Prevention and management of stroke in sickle cell disease. Thalass Rep. 2011;1(12):e25. doi: 10.4081/thal.2011.s2.e25.
   Google Scholar
• Munube D, Katabira E, Ndeezi G, et al. Prevalence of stroke in children admitted with sickle cell anaemia to Mulago Hospital. BMC Neurol. 2016;16(1):175. doi: 10.1186/s12883-016-0704-2.
   PubMedGoogle Scholar
• Driscoll MC, Hurlet A, Styles L, et al. Stroke risk in siblings with sickle cell anemia. Blood. 2003;101(6):2401–2404. doi: 10.1182/blood.V101.6.2401.
   PubMed Web of Science ®Google Scholar
• Zago MA, Pinto ACS. The pathophysiology of sickle cell disease: from the genetic mutation to multiorgan disfunction. Rev Bras Hematol Hemoter. 2007;29(3):207–214.
   Google Scholar
• Quinn CT, Shull EP, Ahmad N, et al. Prognostic significance of early vaso-occlusive complications in children with sickle cell anemia. Blood. 2007;109(1):40–45. doi: 10.1182/blood-2006-02-005082.
   PubMed Web of Science ®Google Scholar
• Foucan L, Ekouevi D, Etienne-Julan M, et al. Early onset dactylitis associated with the occurrence of severe events in children with sickle cell anaemia. The Paediatric Cohort of Guadeloupe (1984–99). Paediatr Perinat Epidemiol. 2006;20(1):59–66. doi: 10.1111/j.1365-3016.2006.00692.x.
   PubMed Web of Science ®Google Scholar
• Martins PRJ, Moraes-Souza H, Silveira TB. Morbimortalidade em doença falciforme. Rev Bras Hematol Hemoter. 2010;32(5):378–383. doi: 10.1590/S1516-84842010000500010.
   Google Scholar
• Aydin S, Yeral H, Oktay G, et al. Associations between transcranial Doppler flow velocities, laboratory parameters, and clinical features in Turkish children with sickle cell disease. J Pediatr Hematol Oncol. 2021;43(7):249–253. doi: 10.1097/MPH.0000000000002255.
   PubMed Web of Science ®Google Scholar
• Silva M, Vargas S, Coelho A, et al. Biomarkers and genetic modulators of cerebral vasculopathy in sub-Saharan ancestry children with sickle cell anemia. Blood Cells Mol Dis. 2020;83:102436. doi: 10.1016/j.bcmd.2020.102436.
   PubMed Web of Science ®Google Scholar
• Kara H, Degirmenci S, Bayir A, et al. Red cell distribution width and neurological scoring systems in acute stroke patients. Neuropsychiatr Dis Treat. 2015;11:733–739. doi: 10.2147/NDT.S81525.
   PubMed Web of Science ®Google Scholar
• Mohindra R, Mishra U, Mathew R, et al. Red cell distribution width (RDW) index as a predictor of severity of acute ischemic stroke: a correlation study. Adv J Emerg Med. 2020;4(2):e24. doi: 10.22114/ajem.v0i0.257.
   PubMedGoogle Scholar
• Li B, Liu S, Liu X, et al. Association between red cell distribution width level and risk of stroke: a systematic review and meta-analysis of prospective studies. Medicine. 2020;99(16):e19691. doi: 10.1097/MD.0000000000019691.
   PubMed Web of Science ®Google Scholar
• Yogitha C. Relationship between red cell distribution width and clinical stroke scoring systems in acute ischemic stroke. Int J Adv Res. 2019;7(3):356–360. doi: 10.21474/IJAR01/8642.
   Google Scholar
• Sabarense AP, Silva CM, Muniz MBSR, et al. Follow-up of children with sickle cell anemia screened with transcranial Doppler and enrolled in a primary prevention program of ischemic stroke. Hematol Transfus Cell Ther. 2022;44(4):478–484. doi: 10.1016/j.htct.2021.05.001.
   PubMedGoogle Scholar
• Silva CM, Giovani P, Viana MB. High reticulocyte count is an independent risk factor for cerebrovascular disease in children with sickle cell anemia. Pediatr Blood Cancer. 201;56(1):116–121. doi: 10.1002/pbc.22680.
   PubMed Web of Science ®Google Scholar
• Carden MA, Fasano RM, Meier ER. Not all red cells sickle the same: contributions of the reticulocyte to disease pathology in sickle cell anemia. Blood Rev. 2020;40:100637. doi: 10.1016/j.blre.2019.100637.
   PubMed Web of Science ®Google Scholar
• Meier ER, Wright EC, Miller JL. Reticulocytosis and anemia are associated with an increased risk of death and stroke in the newborn cohort of the cooperative study of sickle cell disease. Am J Hematol. 2014;89(9):904–906. doi: 10.1002/ajh.23777.
   PubMed Web of Science ®Google Scholar
• Bruniera P. Splenic sequestration crisis in sickle cell disease. Rev Bras Hematol Hemoter. 2007;29(3):259–261. doi: 10.1590/S1516-84842007000300012.
   Google Scholar
• Ladu AI, Aiyenigba AO, Adekile A, et al. The spectrum of splenic complications in patients with sickle cell disease in Africa: a systematic review. Br J Haematol. 2021;193(1):26–42. doi: 10.1111/bjh.17179.
   PubMed Web of Science ®Google Scholar
• Silva Junior GB, Daher EF, Rocha FAC. Osteoarticular involvement in sickle cell disease. Rev Bras Hematol Hemoter. 2012;34(2):156–164. doi: 10.5581/1516-8484.20120036.
   PubMedGoogle Scholar
• Gumiero APS, Brandão MAB, Pinto EALC, et al. Colelitíase no paciente pediátrico portador de doença falciforme. Rev Paul Pediatr. 2007;25(4):377–381. doi: 10.1590/S0103-05822007000400014.
   Google Scholar
• Alvaia MA, Maia HAAS, Nelli AM, et al. Prevalence of priapism in individuals with sickle cell disease and implications on male sexual function. Einstein. 2020;18:eAO5070. doi: 10.31744/einstein_journal/2020AO5070.
   PubMed Web of Science ®Google Scholar
• Hoppe C. Defining stroke risk in children with sickle cell anaemia. Br J Haematol. 2005;128(6):751–766. doi: 10.1111/j.1365-2141.2004.05310.x.
   PubMed Web of Science ®Google Scholar
• Santo AH. Sickle cell disease related mortality in Brazil, 2000–2018. Hematol Transfus Cell Ther. 2022;44(2):177–185. doi: 10.1016/j.htct.2020.09.154.
   PubMedGoogle Scholar
• Cronin RM, Hankins JS, Byrd J, et al. Risk factors for hospitalizations and readmissions among individuals with sickle cell disease: results of a U.S. survey study. Hematology. 2019;24(1):189–198. doi: 10.1080/16078454.2018.1549801.
   PubMed Web of Science ®Google Scholar
• Gardner K, Thein SL. Genetic factors modifying sickle cell disease severity. In: Costa F, Conran N, editors. Sickle cell anemia. Cham: Springer; 2016.
   Google Scholar
• Hulbert ML, McKinstry RC, Lacey JL, et al. Silent cerebral infarcts occur despite regular blood transfusion therapy after first strokes in children with sickle cell disease. Blood. 2011;117(3):772–779. doi: 10.1182/blood-2010-01-261123.
   PubMed Web of Science ®Google Scholar
• Wolf RB, Saville BR, Roberts DO, et al. Factors associated with growth and blood pressure patterns in children with sickle cell anemia: silent cerebral infarct multi-center clinical trial cohort. Am J Hematol. 2015;90(1):2–7. doi: 10.1002/ajh.23854.
   PubMed Web of Science ®Google Scholar
• DeBaun MR, Sarnaik SA, Rodeghier MJ, et al. Associated risk factors for silent cerebral infarcts in sickle cell anemia: low baseline hemoglobin, sex, and relative high systolic blood pressure. Blood. 2012;119(16):3684–3690. doi: 10.1182/blood-2011-05-349621.
   PubMed Web of Science ®Google Scholar
• Loggetto SR, Veríssimo MPA, Darrigo-Junior LG, et al. Guidelines on sickle cell disease: primary stroke prevention in children and adolescents. Associação Brasileira de Hematologia, Hemoterapia e Terapia Celular Guidelines project: Associação Médica Brasileira – 2021. Hematol Transfus Cell Ther. 2022;44(1):85–94. doi: 10.1016/j.htct.2021.09.013.
   PubMedGoogle Scholar